Edward Morrison, MD
Vascular Surgery · Mount Pleasant, SCNPI 1740379916
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $10,027 of the $12,528 with a category attached, or 80.0%. 26 manufacturers reported payments, led by Medtronic at 37.8% of the total.
Across 232 payments — averaging $54.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$5K
- Inari Medical, Inc.$4K
- Bard Peripheral Vascular, Inc.$743
- W. L. Gore & Associates, Inc.$442
- Stryker$415
- Boston Scientific$375
- plus $2K from 20 others
What the payments were for
- Speaking & faculty fees$2,30018%
- Travel & lodging$1171%
- Food & beverage$10,02780%
- Education$841%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 90 | $4,732 |
| Inari Medical, Inc. | 42 | $3,815 |
| Bard Peripheral Vascular, Inc. | 13 | $743 |
| W. L. Gore & Associates, Inc. | 8 | $442 |
| Stryker | 13 | $415 |
| Boston Scientific | 13 | $375 |
| Biocompatibles, Inc. | 7 | $356 |
| Johnson & Johnson | 7 | $315 |
| Silk Road Medical, Inc. | 3 | $288 |
| Organogenesis Inc. | 3 | $176 |
| Smith+Nephew | 4 | $163 |
| Tactile Systems Technology Inc | 3 | $118 |
| Kerecis Limited | 4 | $86 |
| E.r. Squibb & Sons, L.L.C. | 4 | $62 |
| Shockwave Medical, Inc | 2 | $57 |
| Pfizer | 3 | $53 |
| Merz North America, Inc. | 1 | $51 |
| Solventum Corporation | 2 | $51 |
| Catheter Precision, Inc. FKA Ra Medical Systems, Inc. | 1 | $46 |
| Elutia, Inc. | 1 | $46 |
| Paratek Pharmaceuticals, Inc. | 2 | $40 |
| Mimedx Group, Inc. | 2 | $31 |
| Molnlycke Health Care US, LLC | 1 | $21 |
| AbbVie | 1 | $16 |
| Advanced Oxygen Therapy Inc. | 1 | $14 |
| Cook Medical LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FLOWTRIEVER CATHETER, S$3,788
- CT THROMBECTOMY SYSTEM KIT$2,300
- HawkOne$1,090
- Abre$1,085
- Venclose Maven Catheter$334
- TurboHawk$285
- VARITHENA$246
- ENROUTE Transcarotid Neuroprotection System$221
- ENROUTE Transcarotid Stent System$221
- ENHANCE Transcarotid Peripheral Access Kit$221
- ENROUTE 0.014 Guidewire$221
- FlowMet$169
- XARELTO$159
- VIABAHN VBX Balloon Expandable Endoprosthesis$148
- PURAPLY WOUND MATRIX$133
- Affinity$133
- Apligraf$133
- VIABAHN Endoprosthesis with Heparin Bioactive Surface$123
- JETSTREAM$108
How this compares
$12,528 in reported general payments places this provider in the 65th percentile of 99 vascular surgery providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 31 | $23,311 |
| Gabapentin | 21 | $364 |
| ClopidogrelClopidogrel Bisulfate | 12 | $108 |
| Oxycodone Hcl | 15 | $65 |
| Diazepam | 14 | $21 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $53 | $23,31131 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 99 vascular surgery providers in South Carolina.
Other vascular surgery in Mount Pleasant
- John RossOrangeburg$847K
- David DeatonColumbia$609K
- Mathew WoosterWest Columbia$443K
- Sagar GandhiGreenville$236K
- Ravi VeeraswamyCharleston$164K
- Gerald FortunaWest Columbia$143K
- Kristian HochbergCharleston$106K
- Joseph BlasGreenville$101K
- Thomas ApplebyNorth Charleston$89K
- Zachary ArthursCharleston$84K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.